Allergy to eggs can affect the safety of certain medications and vaccines, making it a clinically important consideration beyond dietary management. Egg-derived proteins — particularly ovalbumin and egg lecithin — are present as excipients or residual components in a number of licensed medicines, including some anaesthetic agents, parenteral nutrition lipid emulsions, and certain vaccines. For patients with confirmed IgE-mediated egg allergy, exposure to these proteins carries a risk of allergic reactions ranging from urticaria to anaphylaxis. This article outlines which medications and vaccines require caution or are contraindicated in egg allergy, and how patients and clinicians can navigate treatment safely.
Summary: Egg allergy can contraindicate or require caution with certain medications and vaccines that contain egg-derived proteins, including some parenteral nutrition lipid emulsions and the yellow fever vaccine, though many treatments remain safe with appropriate assessment.
- Only confirmed IgE-mediated egg allergy — not dietary avoidance or non-IgE reactions — typically warrants contraindication or heightened caution with egg-containing medicines.
- Parenteral nutrition lipid emulsions (e.g. Intralipid, Smoflipid) contain egg phospholipids and are contraindicated in confirmed egg allergy; specialist input is required.
- Yellow fever vaccine contains significant egg protein and is contraindicated in individuals with confirmed egg allergy, particularly those with a history of anaphylaxis.
- Propofol contains egg lecithin but egg allergy alone is not a contraindication per UK anaesthetic and BSACI guidance; soya and peanut allergy are the primary concerns.
- Most individuals with egg allergy, including those with prior anaphylaxis, can safely receive inactivated influenza vaccines with ovalbumin content ≤0.12 micrograms/ml per UKHSA and BSACI guidance.
- MMR vaccine is not contraindicated in egg allergy and can be administered safely in standard community settings per NHS guidance.
Table of Contents
- Why Egg Allergy Matters When Prescribing Certain Medications
- Medications Contraindicated or Used With Caution in Egg Allergy
- Vaccines and Egg Allergy: Current NHS and UKHSA Guidance
- What to Tell Your Doctor or Pharmacist About Your Egg Allergy
- Safe Alternatives and Managing Treatment With an Egg Allergy
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Why Egg Allergy Matters When Prescribing Certain Medications
Egg allergy is one of the most common food allergies in the UK, particularly in children, though some individuals carry sensitivities into adulthood. What makes egg allergy clinically significant beyond dietary considerations is that certain medications and vaccines contain egg-derived proteins — most notably ovalbumin — which can trigger allergic reactions ranging from mild urticaria to life-threatening anaphylaxis in sensitised individuals.
The proteins of concern are primarily those found in egg white, particularly ovalbumin and ovomucoid. When these proteins are present as excipients or residual components in pharmaceutical products, they pose a potential risk to patients with confirmed IgE-mediated egg allergy.
It is important to distinguish between different types of egg-related reactions, as the clinical implications differ:
-
IgE-mediated egg allergy — immune-driven, with potential for rapid-onset urticaria, angioedema, or anaphylaxis; this is the category most relevant to medication safety
-
Non-IgE-mediated egg allergy — typically delayed reactions affecting the gut (e.g., vomiting, diarrhoea); less likely to be triggered by trace egg proteins in medicines
-
Egg avoidance without confirmed allergy — for example, dietary preference; not a clinical contraindication
Only confirmed IgE-mediated allergy typically warrants contraindication or heightened caution with egg-containing medications. Patients in whom IgE-mediated egg allergy is suspected but not formally confirmed should be referred to a specialist allergy service for assessment, including skin-prick testing or specific IgE blood tests, in line with NICE CG183 (Drug allergy: diagnosis and management) and BSACI guidance.
Patients should always inform their prescriber of any known egg allergy before starting a new medicine, and prescribers should routinely screen for this during medication reviews. Early identification helps prevent avoidable adverse drug reactions and supports safer prescribing decisions.
Medications Contraindicated or Used With Caution in Egg Allergy
Several licensed medicines contain egg-derived components as active ingredients or excipients. Their use may require careful risk assessment in patients with egg allergy. The most clinically relevant examples include the following:
Propofol is a widely used intravenous anaesthetic agent formulated in a lipid emulsion containing soybean oil and egg lecithin (phosphatide) derived from egg yolk. Importantly, UK anaesthetic and allergy guidance — including that from the Association of Anaesthetists and BSACI — indicates that egg allergy is not a contraindication to propofol. The egg lecithin used is highly purified, and confirmed reactions attributable solely to egg allergy are rare. The propofol SmPC (available via the MHRA's medicines database, emc) highlights soya and peanut hypersensitivity as the primary relevant contraindications, given the soybean oil content. Anaesthetists should nonetheless be informed of any egg, soya, or peanut allergy prior to procedures, so that an appropriate risk assessment can be made.
Parenteral nutrition (PN) lipid emulsions — including commonly used products such as Intralipid, Smoflipid, and ClinOleic — contain egg phospholipids as emulsifiers. In the UK, most available lipid emulsions contain egg-derived excipients and are contraindicated in patients with confirmed egg allergy. Egg-free lipid emulsion alternatives are not routinely available in UK clinical practice. Patients with egg allergy who require parenteral nutrition should be managed by a specialist PN and allergy team, who can advise on individualised strategies, which may include non-lipid PN formulations. SmPCs for individual PN products should be consulted for full excipient and contraindication details.
Some topical and dermatological preparations may contain egg-derived lecithin as an emulsifier. Patients with egg allergy should check excipient lists carefully; pharmacists can assist in identifying suitable alternatives by reviewing the relevant SmPC.
The Summary of Product Characteristics (SmPC) for any medication — accessible via the MHRA's emc database (medicines.org.uk) — lists all excipients and contraindications and should be consulted when prescribing for egg-allergic patients. Pharmacists play a key role in reviewing these details during dispensing.
If you experience any unexpected symptoms after starting a new medication, suspected adverse reactions should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk). Healthcare professionals and patients can both submit reports.
Vaccines and Egg Allergy: Current NHS and UKHSA Guidance
Vaccines have historically been one of the most discussed areas of concern for individuals with egg allergy, as several are manufactured using egg-based culture systems. The most clinically relevant vaccines in this context are the influenza (flu) vaccine and the yellow fever vaccine.
Influenza vaccines are traditionally produced by growing the influenza virus in fertilised hens' eggs, which can result in residual ovalbumin content in the final product. However, NHS and UKHSA guidance has evolved significantly. Current guidance — aligned with the UKHSA Green Book (Influenza chapter) and BSACI recommendations — states that most individuals with egg allergy, including those with a history of anaphylaxis to egg, can safely receive the inactivated influenza vaccine in a primary care setting, provided the ovalbumin content is no more than 0.12 micrograms per millilitre (equivalent to 0.06 micrograms per 0.5 ml dose). This is the threshold considered safe by BSACI. Egg-free influenza vaccines — including cell-based (quadrivalent cell-based influenza vaccine, QIVc) and recombinant formulations — are also available and may be preferred for those with significant egg allergy; patients should discuss these options with their GP or practice nurse.
For children receiving the live attenuated intranasal influenza vaccine (LAIV) as part of the UK childhood immunisation programme, UKHSA guidance indicates that LAIV is generally safe for children with egg allergy, including those with a history of anaphylaxis to egg. However, children who have previously required intensive care for an egg-related anaphylactic reaction should receive LAIV in a specialist setting with appropriate facilities. Clinicians should refer to the current UKHSA Green Book for the most up-to-date recommendations.
Yellow fever vaccine contains significantly higher levels of egg protein and is contraindicated in individuals with a confirmed egg allergy, particularly those with a history of anaphylaxis. Administration should only be considered in a specialist setting with full resuscitation facilities if travel to a high-risk area is unavoidable. The Stamaril SmPC and UKHSA Green Book chapter on yellow fever provide detailed contraindication information.
For other travel vaccines (such as some rabies and tick-borne encephalitis preparations), egg protein traces may be present in certain brands. Patients with egg allergy should ask their travel health provider to check the relevant SmPC before vaccination.
MMR (measles, mumps, and rubella) vaccine is often incorrectly assumed to be contraindicated in egg allergy. The MMR vaccine is grown in chick embryo fibroblast cells and contains negligible egg protein. NHS guidance confirms that egg allergy is not a contraindication to MMR vaccination, and it can be administered safely in standard community settings.
What to Tell Your Doctor or Pharmacist About Your Egg Allergy
Clear communication about egg allergy is essential to safe prescribing and dispensing. Patients should proactively disclose their allergy at every healthcare encounter — including GP appointments, hospital admissions, pre-operative assessments, and pharmacy consultations. This information should be accurately recorded in the patient's medical record and flagged on any allergy alert systems used by the practice or hospital, in line with NICE CG183.
When informing your healthcare team, it is helpful to provide as much detail as possible, including:
-
The nature and severity of your reaction (e.g., skin rash, vomiting, throat swelling, anaphylaxis)
-
Whether the allergy has been formally diagnosed by an allergist or confirmed via skin-prick testing or specific IgE blood tests
-
Any previous reactions to medications or vaccines that may have contained egg-derived components
-
Whether you carry an adrenaline auto-injector (such as an EpiPen or Jext), which indicates a history of severe allergic reactions
Patients should also ask their pharmacist to check the excipient list of any new medication before dispensing, as egg-derived ingredients may not always be immediately obvious from the product name. Pharmacists are trained to review SmPCs and can advise on suitable alternatives where necessary.
Contact your GP or seek urgent medical advice if you experience any unexpected allergic symptoms after starting a new medication, including itching, rash, swelling, difficulty breathing, or dizziness. If you are unsure whether your symptoms require emergency care, you can call NHS 111 for urgent advice. If you experience severe symptoms such as throat tightening or collapse, call 999 immediately and use your adrenaline auto-injector if one has been prescribed.
Suspected allergic reactions to medicines should also be reported to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk). Both patients and healthcare professionals can submit reports, which help to monitor the safety of medicines in the UK.
Safe Alternatives and Managing Treatment With an Egg Allergy
Having an egg allergy does not mean that effective treatment is unavailable — in most cases, safe and clinically appropriate options exist. The key is ensuring that allergy status is well-documented and that prescribers and pharmacists are equipped to make informed decisions.
For patients requiring general anaesthesia, UK guidance from the Association of Anaesthetists and BSACI supports the use of propofol in egg-allergic patients, as egg allergy alone is not a contraindication. Alternative intravenous induction agents (such as thiopental or ketamine, which do not contain egg-derived excipients) may be considered if there is a confirmed hypersensitivity to propofol itself, or to soya or peanut — which are the excipients of greater concern per the propofol SmPC. The anaesthetic team should be informed of all relevant allergies well in advance of any planned procedure.
For influenza vaccination, egg-free options are increasingly available on the NHS. Cell-based (QIVc) and recombinant vaccines are manufactured without the use of eggs and are suitable for individuals with significant egg allergy. Patients should discuss these options with their GP or practice nurse during the annual flu vaccination campaign, with reference to current UKHSA Green Book guidance.
For parenteral nutrition, most lipid emulsions available in the UK contain egg phospholipids and are contraindicated in egg allergy. Management must involve a specialist parenteral nutrition and allergy team, who can develop an individualised plan — which may include non-lipid PN strategies. There is no widely available egg-free lipid emulsion routinely stocked in UK clinical settings, and decisions should be made on a case-by-case basis with specialist input.
More broadly, patients with egg allergy should be encouraged to:
-
Carry a written allergy record or wear a medical alert bracelet
-
Register their allergy on their NHS Summary Care Record, which is accessible to healthcare professionals across settings
-
Seek a formal allergy assessment if they have not already done so — particularly if their allergy history is unclear or if they have experienced severe reactions — via referral to a specialist allergy clinic
With careful planning and open communication between patients and their healthcare team, the vast majority of individuals with egg allergy can receive safe, effective medical treatment without compromising their care.
Frequently Asked Questions
Which medications are contraindicated if I have an egg allergy?
The most clinically significant contraindication for egg allergy is parenteral nutrition lipid emulsions — such as Intralipid and Smoflipid — which contain egg phospholipids and are contraindicated in confirmed egg allergy. The yellow fever vaccine is also contraindicated in individuals with confirmed egg allergy, especially those with a history of anaphylaxis. Always ask your prescriber or pharmacist to check the excipient list of any new medicine, as egg-derived ingredients can appear in a range of products.
Can I have the flu jab if I'm allergic to eggs?
Yes — current NHS, UKHSA, and BSACI guidance confirms that most people with egg allergy, including those with a history of anaphylaxis to egg, can safely receive the inactivated influenza vaccine in a primary care setting, provided the ovalbumin content is no more than 0.12 micrograms per millilitre. Egg-free influenza vaccines, such as cell-based (QIVc) and recombinant formulations, are also available on the NHS and may be preferred for those with significant egg allergy — speak to your GP or practice nurse about the best option for you.
Is propofol safe to use if I have an egg allergy?
Egg allergy alone is not a contraindication to propofol, according to UK guidance from the Association of Anaesthetists and BSACI, as the egg lecithin used is highly purified and confirmed reactions attributable solely to egg allergy are rare. The propofol SmPC identifies soya and peanut hypersensitivity as the primary relevant contraindications, due to the soybean oil content. You should always inform your anaesthetist of any egg, soya, or peanut allergy before a procedure so an appropriate risk assessment can be made.
What is the difference between IgE-mediated and non-IgE-mediated egg allergy when it comes to medications?
IgE-mediated egg allergy is immune-driven and can cause rapid-onset reactions such as urticaria, angioedema, or anaphylaxis — this is the type most relevant to medication safety and the one that may warrant contraindication with egg-containing medicines. Non-IgE-mediated egg allergy typically causes delayed gut symptoms such as vomiting or diarrhoea and is much less likely to be triggered by trace egg proteins in medicines. If you are unsure which type of egg allergy you have, ask your GP for a referral to a specialist allergy clinic for formal assessment.
How do I make sure my egg allergy is recorded so prescribers know about it?
Ask your GP to record your egg allergy on your NHS Summary Care Record, which is accessible to healthcare professionals across different settings, and ensure it is flagged on any allergy alert systems used by your practice or hospital. You should also proactively disclose your allergy at every healthcare encounter — including pre-operative assessments, hospital admissions, and pharmacy consultations — and provide details of the severity of your reaction and whether it has been formally diagnosed. Carrying a written allergy record or wearing a medical alert bracelet can provide an additional safety net.
What should I do if I think I've had an allergic reaction to a medication containing egg?
If you experience mild symptoms such as a rash or itching after starting a new medication, contact your GP or call NHS 111 for urgent advice. If you develop severe symptoms — such as throat tightening, difficulty breathing, or collapse — call 999 immediately and use your adrenaline auto-injector if one has been prescribed. Suspected allergic reactions to medicines should also be reported to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk, which both patients and healthcare professionals can use to help monitor medicine safety in the UK.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
